Host Ashley Vance interviews Alex Colville, co-founder of longevity VC firm Age One, to cut through the hype in the aging field. Colville, a Stanford genetics PhD, discusses the scientific validity of interventions like GLP-1s, the promise of cellular reprogramming, and why he prioritizes high-impact therapies over personal biohacking. He shares insights on investment trends, the role of influencers, and the realistic timeline for extending human healthspan.
Listen ad-free on Castria